Vagus nerve stimulation for drug-resistant epilepsy induced by tuberous sclerosis complex
Tong X, Wang X, Qin L, Zhou J, Guan Y, Teng P, Wang J, Yang Y, Li T, Luan G
Epilepsy & Behavior · 2022
Key finding
The follow-up duration for the 17 patients who underwent VNS treatment ranged from 0.5 to 10 years (mean ± SD: 4.1 ± 3.2 years).
- Condition
- Epilepsy
- Stimulation
- iVNS
- Evidence tier
- Observational / Cohort
- Participants
- 17
Cite this study
Tong, X., Wang, X., Qin, L., Zhou, J., Guan, Y., Teng, P., Wang, J., Yang, Y., Li, T., & Luan, G. (2022). Vagus nerve stimulation for drug-resistant epilepsy induced by tuberous sclerosis complex. Epilepsy & Behavior, 126, 108431. https://doi.org/10.1016/j.yebeh.2021.108431
Related studies in Epilepsy
Can transcutaneous auricular vagus nerve stimulation be considered a viable adjuntive therapy in drug-resistant epilepsy? A systematic review and meta-analysis of randomized controlled trials
Moro et al. · Epilepsy & behavior : E&B · 2025 · Systematic Review / Meta-Analysis
The effect of Vagus nerve stimulation (VNS) on seizure control, cognitive function, and quality of life in individuals with drug-resistant epilepsy: A systematic review article
Melese et al. · Epilepsia open · 2024 · Systematic Review / Meta-Analysis
Effects of vagus nerve stimulation on cognitive function in patients with epilepsy: a systematic review and meta-analysis
Kong et al. · Frontiers in neurology · 2024 · Systematic Review / Meta-Analysis
Transcutaneous auricular vagus nerve stimulation for epilepsy
Zhang et al. · Seizure · 2024 · Systematic Review / Meta-Analysis
Summary by Vagus Research. Always consult the primary source for the authoritative record.